menu
    • menu

    Company profile for Sciwind Biosciences

    NEW Drugs in Dev: 5
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sciwind Biosciences is rapidly emerging as a leading clinical-stage biopharmaceutical company with a clear focus on the exploration and advancement of innovative therapies for the treatment of metabolic diseases. At Sciwind, our dedication lies in the discovery and development of novel therapeutics aimed at halting and even reversing the progression of metabolic disorders, ultimately enhancing the well-being of patients global...
    Sciwind Biosciences is rapidly emerging as a leading clinical-stage biopharmaceutical company with a clear focus on the exploration and advancement of innovative therapies for the treatment of metabolic diseases. At Sciwind, our dedication lies in the discovery and development of novel therapeutics aimed at halting and even reversing the progression of metabolic disorders, ultimately enhancing the well-being of patients globally.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sciwind BiosciencesChina Flag
    Country
    Country
    China
    Address
    Address
    Qiantang New District Hangzhou, Zhejiang
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sciwindbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    German Wound Congress

    German Wound Congress

    Not Confirmed

    envelop Contact Supplier

    German Wound Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    China Signs Off On Pfizer, Sciwind's GLP-1 Weight Loss Drug
    China Signs Off On Pfizer, Sciwind's GLP-1 Weight Loss Drug

    06 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/pfizer-breaks-obesity-market-china-approval-sciwind-partnered-glp-1

    FIERCE PHARMA
    06 Mar 2026
    Share Share
    NMPA Approves Sciwind's Ecnoglutide for Weight Management
    NMPA Approves Sciwind's Ecnoglutide for Weight Management

    06 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-ecnoglutide-injection-approved-by-chinas-national-medical-products-administration-nmpa-for-chronic-weight-management-302706442.html

    PR NEWSWIRE
    06 Mar 2026
    Share Share
    Pfizer in Diabetes Drug Deal with Sciwind Biosciences
    Pfizer in Diabetes Drug Deal with Sciwind Biosciences

    24 Feb 2026

    // BLOOMBERG

    https://www.bloomberg.com/news/articles/2026-02-24/pfizer-secures-china-rights-to-obesity-drug-in-495-million-deal

    BLOOMBERG
    24 Feb 2026
    Share Share
    Sciwind Signs Global Licensing Deal for Metabolic Disease Portfolio
    Sciwind Signs Global Licensing Deal for Metabolic Disease Portfolio

    10 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-global-licensing-and-collaboration-agreement-for-metabolic-disease-portfolio-302347773.html

    PR NEWSWIRE
    10 Jan 2025
    Share Share
    Sciwind BiosciencesPresents GLP-2 Research At UEG Week 2024
    Sciwind BiosciencesPresents GLP-2 Research At UEG Week 2024

    07 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-oral-presentation-on-oral-glp-2-research-progress-at-the-32nd-united-european-gastroenterology-week-ueg-week-2024-302261785.html

    PR NEWSWIRE
    07 Oct 2024
    Share Share
    Sciwind Biosciences Announces Oral Presentations at EASD 2024
    Sciwind Biosciences Announces Oral Presentations at EASD 2024

    05 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-oral-presentations-at-the-european-association-for-the-study-of-diabetes-60th-annual-meeting-easd-2024-302240167.html

    PR NEWSWIRE
    05 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search